Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-25-003679

EVP R&D, Chief Medical Officer gave up 15,083 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 34,393 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2025-02-06 Grant or award +34,393 78,683 D: show line 1 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2025-02-06 Shares withheld for taxes −15,083 $31.39 $473,455 63,600 D: show line 2 in the form
Loading xslF345X05/form4.xml…